These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 36054307)

  • 61. Mechanism of MicroRNA-375 Promoter Methylation in Promoting Ovarian Cancer Cell Malignancy.
    Shu J; Xiao L; Yan S; Fan B; Zou X; Yang J
    Technol Cancer Res Treat; 2021; 20():1533033820980115. PubMed ID: 33928819
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Long non-coding RNA HAL suppresses the migration and invasion of serous ovarian cancer by inhibiting EMT signaling pathway.
    Wu K; Li L; Li L; Wang D
    Biosci Rep; 2020 Mar; 40(3):. PubMed ID: 32039453
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Molecular profiling uncovers a p53-associated role for microRNA-31 in inhibiting the proliferation of serous ovarian carcinomas and other cancers.
    Creighton CJ; Fountain MD; Yu Z; Nagaraja AK; Zhu H; Khan M; Olokpa E; Zariff A; Gunaratne PH; Matzuk MM; Anderson ML
    Cancer Res; 2010 Mar; 70(5):1906-15. PubMed ID: 20179198
    [TBL] [Abstract][Full Text] [Related]  

  • 64. In vivo multiplexed interrogation of amplified genes identifies GAB2 as an ovarian cancer oncogene.
    Dunn GP; Cheung HW; Agarwalla PK; Thomas S; Zektser Y; Karst AM; Boehm JS; Weir BA; Berlin AM; Zou L; Getz G; Liu JF; Hirsch M; Vazquez F; Root DE; Beroukhim R; Drapkin R; Hahn WC
    Proc Natl Acad Sci U S A; 2014 Jan; 111(3):1102-7. PubMed ID: 24385586
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The OPCML tumor suppressor functions as a cell surface repressor-adaptor, negatively regulating receptor tyrosine kinases in epithelial ovarian cancer.
    McKie AB; Vaughan S; Zanini E; Okon IS; Louis L; de Sousa C; Greene MI; Wang Q; Agarwal R; Shaposhnikov D; Wong JL; Gungor H; Janczar S; El-Bahrawy M; Lam EW; Chayen NE; Gabra H
    Cancer Discov; 2012 Feb; 2(2):156-71. PubMed ID: 22585860
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Frequent inactivation of a putative tumor suppressor, angiopoietin-like protein 2, in ovarian cancer.
    Kikuchi R; Tsuda H; Kozaki K; Kanai Y; Kasamatsu T; Sengoku K; Hirohashi S; Inazawa J; Imoto I
    Cancer Res; 2008 Jul; 68(13):5067-75. PubMed ID: 18593905
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Suppression of human ovarian carcinoma metastasis by the metastasis-suppressor gene, BRMS1.
    Zhang S; Lin QD; DI W
    Int J Gynecol Cancer; 2006; 16(2):522-31. PubMed ID: 16681721
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Long noncoding RNA TUG1 facilitates cell ovarian cancer progression through targeting MiR-29b-3p/MDM2 axis.
    Yang X; Xin N; Qu HJ; Wei L; Han Z
    Anat Rec (Hoboken); 2020 Dec; 303(12):3024-3034. PubMed ID: 31930662
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Ribosomal L22-like1 (RPL22L1) Promotes Ovarian Cancer Metastasis by Inducing Epithelial-to-Mesenchymal Transition.
    Wu N; Wei J; Wang Y; Yan J; Qin Y; Tong D; Pang B; Sun D; Sun H; Yu Y; Sun W; Meng X; Zhang C; Bai J; Chen F; Geng J; Lee KY; Fu S; Jin Y
    PLoS One; 2015; 10(11):e0143659. PubMed ID: 26618703
    [TBL] [Abstract][Full Text] [Related]  

  • 70. miR-7 expression in serous ovarian carcinomas.
    Swiercz A; Chechlinska M; Kupryjanczyk J; Dansonka-Mieszkowska A; Rembiszewska A; Goryca K; Kulinczak M; Zajdel M; Sromek M; Siwicki JK
    Anticancer Res; 2015 Apr; 35(4):2423-9. PubMed ID: 25862909
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Functional analysis of the 1p34.3 risk locus implicates GNL2 in high-grade serous ovarian cancer.
    Nakamura K; Reid BM; Chen A; Chen Z; Goode EL; Permuth JB; Teer JK; Tyrer J; Yu X; Kanetsky PA; Pharoah PD; Gayther SA; Sellers TA; Lawrenson K; Karreth FA
    Am J Hum Genet; 2022 Jan; 109(1):116-135. PubMed ID: 34965383
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Inhibition of Ovarian Epithelial Carcinoma Tumorigenesis and Progression by microRNA 106b Mediated through the RhoC Pathway.
    Chen S; Chen X; Xiu YL; Sun KX; Zhao Y
    PLoS One; 2015; 10(5):e0125714. PubMed ID: 25933027
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Upregulation of Circular RNA VPS13C-has-circ-001567 Promotes Ovarian Cancer Cell Proliferation and Invasion.
    Bao L; Zhong J; Pang L
    Cancer Biother Radiopharm; 2019 Mar; 34(2):110-118. PubMed ID: 30376358
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Boosting the apoptotic response of high-grade serous ovarian cancers with CCNE1 amplification to paclitaxel in vitro by targeting APC/C and the pro-survival protein MCL-1.
    Raab M; Kobayashi NF; Becker S; Kurunci-Csacsko E; Krämer A; Strebhardt K; Sanhaji M
    Int J Cancer; 2020 Feb; 146(4):1086-1098. PubMed ID: 31286496
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Genomic markers for ovarian cancer at chromosomes 1, 8 and 17 revealed by array CGH analysis.
    Dimova I; Orsetti B; Negre V; Rouge C; Ursule L; Lasorsa L; Dimitrov R; Doganov N; Toncheva D; Theillet C
    Tumori; 2009; 95(3):357-66. PubMed ID: 19688977
    [TBL] [Abstract][Full Text] [Related]  

  • 76. CCNB1, Negatively Regulated by miR-559, Promotes the Proliferation, Migration, and Invasion of Ovarian Carcinoma Cells.
    Yang X; Zhou S; Yang C; Cao C; He M; Zi S
    Mol Biotechnol; 2022 Sep; 64(9):958-969. PubMed ID: 35262876
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Somatic Mutational Profile of High-Grade Serous Ovarian Carcinoma and Triple-Negative Breast Carcinoma in Young and Elderly Patients: Similarities and Divergences.
    Serio PAMP; de Lima Pereira GF; Katayama MLH; Roela RA; Maistro S; Folgueira MAAK
    Cells; 2021 Dec; 10(12):. PubMed ID: 34944094
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Reduced RBX1 expression induces chromosome instability and promotes cellular transformation in high-grade serous ovarian cancer precursor cells.
    Bungsy M; Palmer MCL; Jeusset LM; Neudorf NM; Lichtensztejn Z; Nachtigal MW; McManus KJ
    Cancer Lett; 2021 Mar; 500():194-207. PubMed ID: 33290867
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Prolactin signaling drives tumorigenesis in human high grade serous ovarian cancer cells and in a spontaneous fallopian tube derived model.
    Karthikeyan S; Russo A; Dean M; Lantvit DD; Endsley M; Burdette JE
    Cancer Lett; 2018 Oct; 433():221-231. PubMed ID: 29981811
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Effects of WWOX gene transfection on cell growth of epithelial ovarian cancer].
    Yan HC; Xue JQ; Lu XY; Wan MR; Feng X; Liu XY
    Zhonghua Fu Chan Ke Za Zhi; 2008 May; 43(5):361-5. PubMed ID: 18953870
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.